NRP1 and colorectal carcinoma: The clinical association of NRP1 with OS was analyzed in 11 studies, the only ones that provided survival-associated data, finding that high expression of NRP1 was significantly correlated with a lower survival probability of liver cancer and CRC patients (HR 1.40, 95% CI 1.14–1.71, p < 0.001).